Additionally, it has been reported that myeloma cells in the BM niche take advantage of a pro-inflammatory microenvironment, especially characterized by the presence of high levels of interleukin-6 (IL-6) produced by BM stromal cells [20]. This evidence concerns the gene IL6 and plasma cell myeloma.